Description:Method and System for Enhanced Extraction and Classification of Retinal Landmarks and Lesions for Diabetic Retinopathy Staging Using Retinal Fundus Images.

PROBLEM STATEMENT:
Diabetic Retinopathy (DR) is a prevalent and severe consequence of diabetes that impacts the retinal blood vessels, potentially resulting in vision impairment. Timely identification and categorization of the severity of diabetic retinopathy are essential for preventing blindness and addressing diabetes-related ocular issues. The retina, a photosensitive tissue located at the posterior segment of the eye, exhibits specific characteristics including the Optic Disc, Blood Vessels, and numerous lesions (e.g., Microaneurysms, Exudates, Hemorrhages) that signify the existence and advancement of diabetic retinopathy (DR).

The features in the retinal pictures, specifically in the fundus images, are not compensated in such factors as the shape, size, quality, and the picture form. However, the presence of retinal cabins abnormalities such as microaneurysms as well as various stages of DR makes it difficult to make conclusive conclusions. Such lesions may be round or oval in shape and in various sizes, thus, may be difficult for automated analysis.

The players of DR diagnosis rely on the examination of retinal photographs, which is time-consuming, prone to inaccuracy and requires referencing a consultant eye specialist. Nevertheless, challenges persist in the detection of the various features in the retina including the Optic Disc, Blood Vessels and Microaneurysms which play a critical role in determining the extent of DR.

It arises from the fact that existing methods often do not consider various appearances and dimensions of lesions and also the complexity of determining the stages of diabetic retinopathy based on the structure of fundus retina. Higher complexity algorithmic approach is necessary to detect and amplify the necessary microanatomy of the retina and some lesions in fundus images, as well as to differentiate the stages of DR by severity. This system has to establish, taking into consideration that retinal picture presentations may vary, the sizes and shapes of lesions, and has to quickly answer the question on the severity of diabetic retinopathy with the help of an algorithm.

In order to address these issues, the proposed solution includes utilizing advanced image processing algorithms and artificial neural networks for the purpose of accurate detection and segmentation of Optic Disc, Blood Vessels, Microaneurysms, and other manifestations on different samples of retinal fundus images to develop an efficient tool for the early diagnosis and grading of Diabetic Retinopathy.
PREAMBLE
Diabetic retinopathy (DR) is a chronic eye disease caused by prolonged high blood sugar levels in individuals with diabetes, leading to damage in the retinal blood vessels. As one of the primary causes of blindness worldwide, early detection and accurate staging of DR are essential for preventing irreversible vision loss. The condition progresses through various stages, from mild non-proliferative DR to proliferative DR, which is characterized by the growth of abnormal blood vessels. Identifying and assessing the severity of retinal landmarks and lesions such as microaneurysms, hemorrhages, exudates, and neovascularization are vital in determining the stage of DR and deciding the appropriate treatment.
Fundus photography, which captures high-resolution images of the retina, has become the gold standard for DR diagnosis. However, manual inspection of these images by ophthalmologists is time-consuming, subjective, and prone to human error. Given the increasing prevalence of diabetes and the shortage of skilled professionals, there is a pressing need for automated systems to assist in the timely and accurate diagnosis of DR.
Recent advances in machine learning, particularly deep learning, have significantly improved the accuracy of image analysis tasks. By leveraging convolutional neural networks (CNNs) and other image processing techniques, it is now possible to automatically detect and classify retinal lesions, providing a reliable means for DR staging. This research focuses on the development of a comprehensive system that integrates these technologies to enhance the extraction and classification of retinal landmarks and lesions from fundus images.
The proposed system aims to improve the overall efficiency and precision of DR detection by automating the segmentation and classification of retinal lesions. It incorporates a multi-stage pipeline involving pre-processing, feature extraction, and lesion classification to ensure high accuracy. The ability to automatically detect and stage DR not only reduces the burden on healthcare professionals but also ensures faster decision-making in clinical settings. This approach holds the potential to revolutionize diabetic retinopathy screening, making it more accessible and effective in combating this global public health issue.

EXISTING SOLUTIONS
1. List any known products, or combination of products, currently available to solve the same problem(s). What is the present commercial practice?
Established Products and Technologies: Numerous existing solutions and commercial offerings endeavor to automate the detection and classification of Diabetic Retinopathy (DR) via retinal fundus pictures. These solutions generally concentrate on identifying critical features such as the Optic Disc, Blood Vessels, and lesions including Microaneurysms and Exudates, as well as categorizing the stages of Diabetic Retinopathy (DR). The prevalent products and technology in this domain include:

Solutions Based on Deep Learning:
 EyeArt (Eye Diagnostics Inc.) employs deep learning algorithms to autonomously identify and categorize phases of diabetic retinopathy from retinal fundus images. The technology is FDA-approved and is applicable for assessing diabetic retinopathy in diabetic individuals. Nonetheless, although EyeArt provides strong diabetic retinopathy detection, its capacity to recognize diverse lesion forms and sizes, or to manage photos with considerable appearance fluctuations, is constrained.
 RetinaNet (DeepMind, Google): RetinaNet, a model based on deep learning created by Google’s DeepMind, is utilized for the segmentation and classification of retinal pictures. It emphasizes the detection of characteristics such as microaneurysms, hemorrhages, and exudates to ascertain the existence of diabetic retinopathy (DR). Nonetheless, obstacles persist in identifying lesions of differing dimensions and delivering a dependable classification of diabetic retinopathy stages, especially in instances of modest or early-stage diabetic retinopathy.

Conventional Image Processing Solutions:
 Optical Coherence Tomography (OCT) Scans and Fundus Imaging Devices (Zeiss, Topcon, Canon): These devices are employed in clinical environments to obtain retinal pictures for manual analysis. They utilize modern imaging technologies such as Fundus photography and OCT to obtain high-resolution pictures for the identification of retinal landmarks and lesions. Nevertheless, these solutions necessitate proficient individuals for interpretation, rendering them time-intensive and subjective. Moreover, they do not offer automatic or real-time assessments of lesion morphology, dimensions, or diabetic retinopathy stages.

Diabetic Retinopathy Screening Tools (IDx-DR):
 IDx-DR is an FDA recognized imaging AI solution which analyzes the image of the retina to diagnose DR. It uses the classification model of Yes/No or Referable DR to help the clinicians to identify the patients for further diagnosis. The method is mainly used solely for screening of DR but does not provide a means of grading the severity, or recognizing the different sizes and types of lesions.

Alternative Machine Learning Models:
 DeepDR (Stanford University): A machine learning model created by Stanford for the detection of diabetic retinopathy from retinal fundus pictures. The model employs a convolutional neural network (CNN) to identify diabetic retinopathy (DR) in images and assess its severity. The method can identify diabetic retinopathy (DR), but it encounters challenges in reliably segmenting and classifying lesions of varying sizes and shapes, which is essential for effective DR staging.

2. Limitations of Existing Solutions:
 Limitation in the identification of a variety of lesion size and shapes: There are problems in identifying and segmenting shapes such as microaneurysms and other lesions which has up to date required complex shapes and sizes. Many models are developed to detect only a limited number of types of lesion and do not have the ability to handle various lesions in different stages of diabetic retinopathy.
 Inadequate classification of all the phases of the DR: The contemporary goods usually assess the existence of diabetic retinopathy and if it exists, they classify it into a limited number of classes, say, mild or severe. These approaches do not help in providing a complete picture of the severity of DR and its subtypes which are the essential for the correct treatment and follow-ups.
 Dependence on Qualified Assessment: Although fundus cameras and OCT scanners, which are commercially available, can be used to provide high quality retinal images, such systems require intervention from professionals to analyze them. This leads to timely diagnosis being affected and is apt to human error especially in complicated cases or cases with small lesions or early stage diabetic retinopathy.
 Limited Applicability for Massive Population Screening: Some of the applications that support AI resolutions to clinicians, do not work well for population-level screening especially in developing or rural areas where there are few healthcare personnel. To the same effect, most methods are demonstrated to have low performances on low-quality images or images captured under different conditions, and conditions they are not suitable for large-scale screening.

Current Commercial Practices:
 Telemedicine Platforms (e.g., Tele-Ophthalmology Solutions by Ophthalmic Technologies): These platforms facilitate remote screening of diabetic retinopathy with AI-driven diagnostic tools and retinal fundus pictures, allowing for image analysis at distant places and delivering diagnostics without the necessity of specialist ophthalmologists.
 Public health agencies in numerous countries use extensive screening programs, such as the NHS Diabetic Retinopathy Screening Program, utilizing automated retinal imaging technologies for the detection of diabetic retinopathy (DR). These techniques assist in identifying patients necessitating additional diagnostic evaluation, although frequently lack the capacity to comprehensively characterize the phases or severity of diabetic retinopathy (DR).

Deficiencies of Existing Solutions:
 Inadequate Management of Varied Lesions: Current techniques for lesion detection lack the robustness necessary to accommodate the diverse forms, sizes, and appearances of lesions encountered at various stages of diabetic retinopathy (DR).
 Inadequate DR Staging Capability: Most existing systems prioritize the detection of diabetic retinopathy (DR) but do not reliably classify it into distinct severity stages (e.g., mild, moderate, severe), which is essential for effective treatment and monitoring.

This section delineates the current solutions, products, and patents pertinent to retinal landmark extraction, diabetic retinopathy detection, and categorization. It also underscores the principal deficiencies of these existing methodologies, establishing the foundation for the suggested solution to efficiently rectify these weaknesses.

2. In what way(s) do the presently available solutions fall short of fully solving the problem?
Research efforts in DR diagnosis and classification have made significant advances but to be considered as useful in the following areas where the current techniques have their inherent problems: accurate localization of retinal structures of interest, identification of the lesions and DR grading. These deficiencies encompass:

Insufficient Identification of Diverse Lesion Morphologies and Dimensions:
 Present Solution: Most powerful modern machine learning selections are aimed at recognizing particular retinal lesions like microaneurysms, exudates, and microhemorrhages, and often have problems with lesions that can be various in size, shapes, and appearances. However, these techniques are rather not so effective to determine less complex or hard to see lesions of early stage of diabetic retinopathy.
 Limitation: The heterogeneity in lesion morphology and dimensions among various patients and stages of diabetic retinopathy complicates proper identification and classification by conventional approaches, resulting in overlooked diagnosis or erroneous staging.

Inadequate Classification of All Stages of Diabetic Retinopathy:
 Existing Solutions: Although certain methods identify the existence of diabetic retinopathy (DR) and categorize it as mild, moderate, or severe, numerous solutions fail to offer accurate categorization across the complete range of DR stages. Current techniques frequently do not distinguish between early-stage diabetic retinopathy and advanced-stage diabetic retinopathy.
 The accurate staging of diabetic retinopathy is essential for establishing the suitable therapy and monitoring strategy. Many methods lack the capability to classify the severity of diabetic retinopathy by comprehensive lesion analysis, hence failing to furnish the complete information necessary for effective patient care.

Restricted Flexibility in Response to Fluctuations in Retinal Image Quality:
 Existing Solutions: Commercial devices and automated systems often depend on high-resolution retinal pictures obtained in controlled settings. Nonetheless, actual fundus photographs might significantly differ in quality, resolution, and illumination conditions.
 Limitation: Numerous systems encounter difficulties in analyzing retinal images of subpar quality or sourced from various imaging devices, potentially leading to uneven performance across heterogeneous datasets, especially in non-optimal clinical environments or telemedicine applications.

Reliance on Manual Intervention for Complicated Cases:
 Present Solutions: Notwithstanding the progress in AI and machine learning models, numerous retinal screening methods continue to necessitate human interaction for the validation or refinement of results, particularly in complex or nuanced instances.
 The reliance on human expertise constrains the scalability of current solutions for extensive screening programs and distant regions without ophthalmologists. The objective of achieving fully automated, real-time screening has not been realized in numerous instances.

Insufficient Generalization Across Varied Populations:
 Contemporary Solutions: Numerous existing algorithms are trained on restricted datasets or data sourced from certain groups. There are some limitation of these models: they can perform poorly across multiple demographic or ethnicities, as these groups differ in their retinal features.
 Limitation: it may be limiting to generalize which may lead to poor prediction of results when tested on other or different population set, maybe because there was little or no representation in the training.

Incapability to Manage Multi-Lesion Detection and Classification:
 Current existing solutions: Most of the existing methods work to classify the existence of one lesion category at a time or the identification of individual lesions only. In complex environments, many a times several lesions may occur at the same time bringing about the need for models that can sort and grade the multiple lesions of different kinds.
 Limitation: The only drawback which would be important while diagnosing many of the lesions is, the ability to classify the classification of the total extent of the diabetic retinopathy in the patient. The current solutions fail to capture and categorize the relationships between different lesions, including microaneurysms and exudates, that are common in the later stages of DR.

Inadequate Data Integrity Protocols:
 Current Solutions: Most of the existing systems do not place much concern on the security and/or the integrity of data, which is crucial in today’s health care applications that deal with patients’ data.
 Limitation: Possible concerns of data manipulation, erroneous entries or wrong diagnosis emanating from limited data integrity checking mechanisms may be realized especially when working with big scale automation of screening programs.

These shortcomings indicate a need for a more complex system to be developed for retinal landmarks extraction, numerous lesion patterns and variations of size, integrating complete and accurate classification of diabetic retinopathy stages alongside data consistency across all possible classes of retinal image and also patients from different age groups. The current system, therefore, has certain shortcomings, which the proposed system attempts to eradicate by incorporating detailed and enhanced image amplification, effective deep learning system, and dynamic classification system to enhance and improve the diabetic retinopathy detection and staging system.

3. Conduct key word searches using Google and list relevant prior art material found?
Diabetic Retinopathy, Retinal Landmark Extraction, Deep Learning, Image Processing, Data Integrity Verification

D.DESCRIPTION OF PROPOSED INVENTION:
How does your idea solve the problem defined above?
A. Identity Based Remote Data Integrity Checking
The invention aimed at enhancing the identification of the retinal landmarks such as the Optic Disc, Blood Vessels, and Microaneurysms; and classifying DR based on DR stages of severity. It performs the retinal image analysis to classify different lesions, changes in the vessels and other features relevant to grading of DR. The invention also further includes Identity-Based Remote Data Integrity Verification (IBRDIV) to ensure the credibility and security of the data collected from the network.

The Proposed Invention Addresses the Issue: Improved Retinal Landmark Extraction:
 The technology also helps enhance and detect other necessary features of the Retina such as Optic Disc, Blood Vessels, Microaneurysms etc. with the help of advanced deep learning. It is designed to work with retinal images of different quality and resolution, as well as different look, which makes the model resistant to actual data taken from devices of ophthalmoscopy.
 The deep learning model consists of a Convolutional Neural Network (CNN) commonly used in segments images and identifies the position of the retinal landmarks. A Residual Network (ResNet) improves feature extraction and gives the network a capability of learning deeper and more complex features from fundus images. In this case, basic processes like contrast enhancement and noise reduction are applied to the input images so that the detection algorithms can operate as satisfactorily as possible.

Detection and Classification of Lesions:
 The main pathological features associated with DR include microaneurysms, exudates and hemorrhages. The method accustoms these lesions that may appear in various form, dimensions and morphology. That is why the model proposed uses the attention mechanism to focus on specific regions, which are more prone to lesions in an image.
 In the process the expertise of the program is to partition the Retinal landmarks then analyze the features particularly the lesion features lastly categorizes the lesions into several types using classification algorithms. This will help the system in picking up even subtle signs of lesions and then sort them by size, shape or stage.

Staging of Diabetic Retinopathy:
 The method automatically classifies the classified lesions and retinal landmarks into the different stages of DR, namely mild, moderate, severe and proliferative DR based on the shape as well as the distribution of the lesions.
 The model is trained using labeled datasets; some of which are the fundus images of eyes which are labelled with stage of DR. In order to accurately assign the correct stage of DR, the deep learning model works in conjunction with machine learning classifiers such as support vector machines as well as random forests. This one is fairly comprehensive as it goes a step further to consider both the type and stage of the lesions, to avoid misdiagnosis when treating the patient.

Identity-Based Remote Data Integrity Verification (IBRDIV):
 IBRDIV is introduced as a feature of the system to ensure the validation of the data used for training and predict the results. This procedural ensures that any information that is entered and uploaded concerning the patients is safe and intact from the real world.
 Every photopic retinal image is labelled with a unique identification number when the image is captured. This identification is encrypted and the data that is exchanged is confirmed through cryptography to ensure that there is no manipulation of data in the course of transmission or even in the process of being worked on. This is particularly the case in the clinical setting where data accuracy is critical in order to provide the right diagnosis and treatment.
Scalability and Real-Time Processing
 The developed device is designed to provide real time operating system for fast examination of retinal fundus images. It is capable of handling large sets of data and efficient in processing large-scale screenings or even virtual consultations.
 The cloud computing resources are used to store, process as well as train the models in the system. It can process a large amount of retinal images makes it suitable for telecare and screening projects on global basis.

Ongoing Education and Adjustment:
 The technology improves the efficiency of its detection and classification with each new data. It uses incremental learning to capture changes in the form of lesions, variations in the quality of retinal picture and alterative patterns of diabetic retinopathy.
 The model employs feedbacks and performance measures, adjustment of the parameters of the model is done with the latest information obtained. This continuous learning also helps the system to improve its algorithms over time and therefore increasdelity and reliability in the detection of the lesion as well as staging of diabetic retinopathy.
It must also include the design of a system that the be integrated and able to perform the functionalities of the automatic retinal landmark extraction, lesion detection, diabetic retinopathy staging and data checking accuracy automatically.

The system functions through the subsequent steps:
 Data Sources and Cleaning: The retinal fundus images are captured and preparation of the images is done by removing background noise.
 The Deep Learning Model (ResNet combined with an Attention Mechanism) and there is the Feature Detection of Lesion.
 Turkey’s Classification and Staging of Diabetic Retinopathy and Lesions: Further, the identified lesions are classified, and the stage of diabetic retinopathy is determined.
 IBRDIV Integration: Data integrity is guaranteed through IBRDIV, inhibiting data tampering.
 The technology offers real-time forecasts and is deployable within a cloud architecture for enhanced scalability.
B. System Components
The Retinal Landmark Extraction and Diabetic Retinopathy Staging System comprises of the elements that work together to locate, enhance and categorize the landmarks and lesions on the fundus images besides ensuring data validation and real-time DR staging. It includes the data acquisition, deep learning models, lesion classification and verification procedures and all the elements composing the system work in harmony, while keeping the opportunity to scale up effortlessly.
Module for Data Acquisition and Preprocessing:
 Retinal Fundus Image Collection: The system obtains these retinal fundus images in different sources such as fundus cameras, digital fundus cameras, and OCT systems to use them for detection and classification.
 Preprocessing: This phase improves the image contrast, minimizes the noise and equalizes picture quality thus very important for feature extraction. There is scaling, normalization, and augmentation to correct size, shape and structural differences of the datasets.
Deep Learning Architecture:
 The proposed system is, therefore, established on the Residual Convolutional Neural Network (ResNet) that captures essential features from retinal fundus images. Connection residuals help to establish deeper connections with the help of which a model can learn complex, hierarchal features in an image.
 The application of the attention mechanism aims to focus more on such potential regions which contain more feature like microaneurysms, hemorrhages and exudates in retinal images with complex shapes and sizes of the lesions.
Detection and Classification of Lesions:
 Lesion Identification: The method identifies retinal lesions including microaneurysms, exudates, hemorrhages, and additional indicators of diabetic retinopathy. The model employs image segmentation and object identification techniques to identify and name lesions of diverse forms, sizes, and appearances.
 Lesion Classification: Upon identification, the system categorizes lesions according to their attributes (e.g., size, shape, and location) to ascertain the stage of diabetic retinopathy, which varies from mild to severe stages.

Staging of Diabetic Retinopathy:
 Stage Classification: The strategy used to classify the level of DR is based on lesions identified and landmarks of the retina that have predetermined levels such as mild non-proliferative DR, moderate non-proliferative DR, severe non-proliferative DR and proliferative DR. The classification integrated in this manner involves employing a machine learning classifier in the form of the support vector machine (SVM) or the random forest other than the deep learning model.
 Severity Mapping: It involves combined lesion size and distribution with severity standards in order to generate a clear distinction of the various phases of diabetic retinopathy for proper planning of treatment plans for the physicians.

Identity-Based Remote Data Integrity Verification (IBRDIV):
 The system guarantees the authentication and encryption of all images and associated data during transmission through identity-based encryption methods. This ensures that the diagnostic data is unaltered and genuine, so averting possible inaccuracies or deceit.
 Secure Data Transmission: Each collected retinal image is associated with a unique encrypted identification, and the system employs secure communication protocols to transport data to the central server or cloud storage, so ensuring privacy and integrity.
Real-Time Inference and Prediction:
 It has the capability for real-time inference to decide the status of the retinal picture, and provide early and quick comments/suggestions which concern the stage of diabetic retinopathy (DR). The trained ResNet model classifies the severity of the diabetic retinopathy within a few seconds, making it appropriate for use in high-throughput screening scenarios.
 Alert System: If DR is detected then the system is capable of automatically sending out alerts to the heath care practitioners or diagnostic facilities about the severity of DR and the need for further action or for an inspection.

Cloud-Based Storage and Processing Framework:
 Scalable Data Storage: The system utilizes cloud platform for storage as well as processing of large volumes of retinal pictures. It enables easy and efficient storage and organization of data, with fast access to powerful computing services for computation and applying the models to the data.
 Parellel Processing: this means that the system’s processing can be distributed in various apparatus with an increased capacity, useful where there is bulk screening, telemedicine and others.

Performance Evaluation and Ongoing Education:
 Model E valuation: The system constantly evaluates the deep learning model’s performance with accuracy, precision, recall, and F1-score for the identification of the presence and staging of the lesions as well as diabetic retinopathy.
 Incremental Learning: With increase in the amount of data, the model adapts and improves through incremental learnings so that it can efficiently capture new structures of retinal pictures and increase overall accuracy of classification in the future.

Visualization and Reporting Interface:
 It includes information regarding the identified characteristics of the lesions, stages of classification of diabetic retinopathy, as well as additional data for doctors.
 Interactive Tools: The images can be annotated to allow healthcare providers to look at the various stages of rejuvenation and deterioration of the retina resulting from diabetes related retinopathy; additionally, further diagnostic information is received to assist the physician in their decision making.

Fig 1. System Architecture Flowchart for Enhanced Diabetic Retinopathy Staging and Lesion Classification.

E.NOVELTY:
This invention's innovation consists of combining Residual Convolutional Neural Networks (ResNet) with an attention mechanism and dynamic data integrity verification (IBRDIV) to precisely extract retinal landmarks, identify lesions of diverse sizes and shapes, and classify stages of Diabetic Retinopathy in real-time, thereby enhancing reliability, scalability, and security for automated DR screening.

F. COMPARISON:
The proposed Residual Convolutional Neural Network (ResNet) incorporating an Attention Mechanism and Data Integrity Verification presents numerous advantages compared to current systems for diabetic retinopathy (DR) detection and classification.

Improved Identification of Lesions with Diverse Morphologies and Dimensions:
• The incorporation of an attention mechanism into the ResNet model facilitates the system's ability to concentrate on essential areas of retinal images, hence enabling the detection of lesions of diverse sizes, forms, and characteristics, even in early-stage diabetic retinopathy or images exhibiting subtle alterations.
• Current methods: Numerous present methods inadequately identify lesions of varying shapes and sizes, especially tiny lesions like microaneurysms, which are essential for the early detection of diabetic retinopathy.

Precise DR Staging Across All Severity Levels:
• The approach precisely categorizes diabetic retinopathy into all stages—mild, moderate, severe, and proliferative—based on lesion characteristics, facilitating a more nuanced and actionable diagnosis.
• Current Solutions: Existing systems mostly concentrate on identifying the existence or absence of diabetic retinopathy (DR) or categorizing it into general classifications (e.g., mild versus severe), neglecting to offer accurate stage classification essential for treatment decisions.

Dynamic Loss Function for Enhanced Detection of Minority Classes:
• Proposed Solution: In the adaptive loss function, modification occurs during training to ensure that the model doesn’t neglect details such as microscopic or faint lesions in the minority class (for instance, small microaneurysms) for early diagnosis of DR.
• Current Solutions: Most of the systems in use utilize static loss functions or presumptions of the class weights, which are not very efficient at handling the task of imbalanced datasets, leaving the class of minority with low consideration and poor results.

Identity-Based Remote Data Integrity Verification (IBRDIV):
• Proposed Solution: IBRDIV implements a system of ensuring that the retinal pictures and diagnosis data that is being transmitted or processed is as original and secure as it can be, the chance of the picture or data being tampered with or manipulated fraudulently is minimal.
• The Current data systems: Most current systems do not show adequate data integrity which poses risks in clinical practicums where wrong or changed data can cost more than lives.

Scalability and Real-Time Processing for Extensive Screening:
• Proposed Solution: The system is architected for scalability through cloud-based architecture, facilitating real-time processing of extensive datasets for comprehensive DR screening. It can efficiently and remotely manage large-scale population screenings, especially in underserved or rural regions.
• Current methods are frequently constrained to smaller datasets or necessitate costly, specialized equipment, hence hindering their scalability. Furthermore, several systems lack the capability for real-time processing or rely on manual intervention, rendering them less appropriate for extensive inspections.

Enhanced Generalization Across Varied Populations:
• Suggested Solution: Since the model learns with heterogeneous datasets, the program is capable of being adapted from one race, age set, and quality of retinal images making it very reliable and accurate for multiple application in the clinical practice.
• Current Solutions: Many existing algorithms are developed based on some condition, cable or limited, data set and therefore, they are not likely to perform well in detecting diabetic retinopathy in racially and ethnically diverse population with non-homogeneously distributed retinal features and images of variable quality.

Thorough and Completely Automated System:
• Proposed Solution: The complete procedure, encompassing retinal landmark extraction and diabetic retinopathy stage categorization, is entirely automated. The system delivers instantaneous forecasts and notifications with minimal human involvement, hence decreasing delays and enhancing diagnostic processes.
• Current Solutions: Although existing technologies automate lesion identification, they frequently necessitate manual validation or interpretation by professionals, resulting in delays and possible diagnostic errors.
, Claims:G. ADDITIONAL INFORMATION:
Claim Set:
1. A technique for identifying and categorizing Diabetic Retinopathy (DR) utilizing retinal fundus pictures, consisting of:
 Obtaining retinal fundus images from a patient with a digital fundus camera or optical coherence tomography (OCT) imaging instrument.
 Processing the obtained images to improve quality, eliminate noise, and standardize features for effective extraction.
 Utilizing a Residual Convolutional Neural Network (ResNet) augmented with an attention mechanism to extract retinal landmarks, including the Optic Disc, Blood Vessels, and Microaneurysms.
 Identifying and categorizing retinal abnormalities such as microaneurysms, hemorrhages, and exudates with machine learning algorithms.
 Classifying the severity of diabetic retinopathy into phases, including mild, moderate, severe, and proliferative, depending on lesion size, location, and intensity.
 Delivering real-time classification and automated notifications to healthcare professionals based on identified diabetic retinopathy stages.
 Identity-Based Remote Data Integrity Verification (IBRDIV) ensures the authenticity and unaltered state of the data utilized for training and inference, hence preventing data tampering.
2. The technique specified in claim 1, wherein the attention mechanism specifically concentrates on areas in the image indicative of minority class lesions (e.g., small microaneurysms), enhancing lesion identification precision in early-stage diabetic retinopathy.
3. The technique specified in claim 1, wherein the dynamic loss function modifies the training weights in real-time to emphasize the detection of minority class lesions, thereby enhancing accuracy for small lesions that are vital for early diabetic retinopathy detection.
4. The technique specified in claim 1, wherein data integrity verification guarantees the authentication and encryption of all patient data, ensuring that the data transmitted for processing remains unmodified and safe.
5. The technique specified in claim 1, wherein the system is deployable on cloud architecture for scalable real-time screening and remote diagnosis, facilitating extensive DR screening initiatives.